|
Volumn 89, Issue 3, 2011, Pages 343-345
|
Ethical issues in developing pharmacogenetic research partnerships with American indigenous communities
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CIVIL RIGHTS;
DIABETES MELLITUS;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
ETHNIC DIFFERENCE;
FRAUD;
GENETICS;
HEALTH CARE DELIVERY;
HEALTH DISPARITY;
HUMAN;
HUMAN RIGHTS ABUSE;
INDIGENOUS PEOPLE;
INFORMED CONSENT;
INHERITANCE;
MEDICAL RESEARCH;
NOTE;
PHARMACOGENETICS;
PRIORITY JOURNAL;
RESEARCH ETHICS;
SCHIZOPHRENIA;
UNITED STATES;
ALASKA NATIVE;
AMERICAN;
AMERICAN INDIAN;
CLINICAL PRACTICE;
DRUG RESEARCH;
EMPOWERMENT;
HEALTH CARE PERSONNEL;
JUSTICE;
MEDICALLY UNDERSERVED;
NATIONAL HEALTH ORGANIZATION;
NEGLIGENCE;
PARTICIPATORY RESEARCH;
PHARMACOGENOMICS;
PRESCRIPTION;
PUBLIC-PRIVATE PARTNERSHIP;
REVIEW;
RISK BENEFIT ANALYSIS;
TRUST;
COMMUNITY-BASED PARTICIPATORY RESEARCH;
COOPERATIVE BEHAVIOR;
GENETIC RESEARCH;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INDIANS, NORTH AMERICAN;
MEDICALLY UNDERSERVED AREA;
PHARMACEUTICAL PREPARATIONS;
PHARMACOGENETICS;
PHYSICIAN'S PRACTICE PATTERNS;
TRUST;
UNITED STATES;
|
EID: 79951782374
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2010.303 Document Type: Note |
Times cited : (47)
|
References (5)
|